ABSTRACT
Purpose (1) To assess the morphology and 3D displacements of the eye globe and optic nerve (ON) in adduction/abduction using magnetic resonance imaging (MRI). (2) To assess differences between healthy emmetropic and highly myopic (HM) subjects.
Methods MRI volumes of both eyes from 18 controls and 20 HM subjects in primary gaze, abduction and adduction (15°) were postprocessed. All ONs were manually-segmented and fitted to a 3D curve to assess ON tortuosity. ON displacements were evaluated in 4 quasicoronal planes which were perpendicular to the ON in primary gaze and 3 mm apart.
Results Axial length was higher in the HM group (28.62±2.60 vs 22.84±0.89 mm; p<0.0001). Adjusted ON tortuosities (i.e., ON tortuosities estimated before myopia onset) were lower in HM eyes (0.9063±0.0591) versus controls (1.0152±0.02981) in primary gaze, adduction (0.9023±0.05538 versus 1.0137±0.0299) and abduction (0.9100±0.0594 versus 1.0182±0.0316); p<0.0001 for all cases. In all eyes, ON displacements in adduction were significantly different from those in abduction in the naso-temporal direction (p<0.0001 in all planes) but not in the supero-inferior direction. ON displacements in the posterior segments of the ON were smaller in the HM group in both gaze directions and were larger in the anterior-most ON segment in adduction only.
Conclusions The adjusted tortuosity of the ON was significantly lower in HM eyes, suggesting that eyes destined toward HM exhibited higher ON traction forces during eye movements before the onset of myopia. Our ON metrics may be valuable to explore a potential link between eye movements and axial elongation.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
n/a.
Funding Statement
The study was supported by Beijing Natural Science Foundation (7194288 [XW]), by the Singapore Ministry of Education Academic Research Funds Tier 1 (R-397-000-294-114 [MG]) and Tier 2 (R-397-000-280-112 and R-397-000-308-112 [MG]), by K08 Grant (QVH, 1 K08 EY023595, National Eye Institute, NIH), the Louis V. Gerstner Jr. Scholars Career Development Award (QVH), Clinician Scientist Award (QVH, CSA-INVMay0011, National Medical Research Council, Singapore), philanthropic donation from John Cushman (QVH) and The Macula Foundation Inc., New York, NY (LAY). The sponsor or funding organization had no role in the design or conduct of this research.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional Review Board (IRB)/Ethnics Committee approval was obtained from Columbia University.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data available from the authors upon reasonable request.
